Index
1 Bio-based Pentylenediamine Market Overview
1.1 Bio-based Pentylenediamine Product Overview
1.2 Bio-based Pentylenediamine Market Segment by Type
1.2.1 Purity Above 99.5%
1.2.2 Purity Above 99.9%
1.3 Global Bio-based Pentylenediamine Market Size by Type
1.3.1 Global Bio-based Pentylenediamine Market Size Overview by Type (2018-2029)
1.3.2 Global Bio-based Pentylenediamine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Bio-based Pentylenediamine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Bio-based Pentylenediamine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Bio-based Pentylenediamine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Bio-based Pentylenediamine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Bio-based Pentylenediamine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Bio-based Pentylenediamine Sales Breakdown by Type (2018-2023)
2 Global Bio-based Pentylenediamine Market Competition by Company
2.1 Global Top Players by Bio-based Pentylenediamine Sales (2018-2023)
2.2 Global Top Players by Bio-based Pentylenediamine Revenue (2018-2023)
2.3 Global Top Players by Bio-based Pentylenediamine Price (2018-2023)
2.4 Global Top Manufacturers Bio-based Pentylenediamine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Bio-based Pentylenediamine Market Competitive Situation and Trends
2.5.1 Bio-based Pentylenediamine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Bio-based Pentylenediamine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bio-based Pentylenediamine as of 2022)
2.7 Date of Key Manufacturers Enter into Bio-based Pentylenediamine Market
2.8 Key Manufacturers Bio-based Pentylenediamine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Bio-based Pentylenediamine Status and Outlook by Region
3.1 Global Bio-based Pentylenediamine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Bio-based Pentylenediamine Historic Market Size by Region
3.2.1 Global Bio-based Pentylenediamine Sales in Volume by Region (2018-2023)
3.2.2 Global Bio-based Pentylenediamine Sales in Value by Region (2018-2023)
3.2.3 Global Bio-based Pentylenediamine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Bio-based Pentylenediamine Forecasted Market Size by Region
3.3.1 Global Bio-based Pentylenediamine Sales in Volume by Region (2024-2029)
3.3.2 Global Bio-based Pentylenediamine Sales in Value by Region (2024-2029)
3.3.3 Global Bio-based Pentylenediamine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Bio-based Pentylenediamine by Application
4.1 Bio-based Pentylenediamine Market Segment by Application
4.1.1 Spinning
4.1.2 Engineering Materials
4.1.3 Medicine
4.1.4 Pesticides
4.1.5 Organic Synthesis
4.1.6 Others
4.2 Global Bio-based Pentylenediamine Market Size by Application
4.2.1 Global Bio-based Pentylenediamine Market Size Overview by Application (2018-2029)
4.2.2 Global Bio-based Pentylenediamine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Bio-based Pentylenediamine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Bio-based Pentylenediamine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Bio-based Pentylenediamine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Bio-based Pentylenediamine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Bio-based Pentylenediamine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Bio-based Pentylenediamine Sales Breakdown by Application (2018-2023)
5 North America Bio-based Pentylenediamine by Country
5.1 North America Bio-based Pentylenediamine Historic Market Size by Country
5.1.1 North America Bio-based Pentylenediamine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Bio-based Pentylenediamine Sales in Volume by Country (2018-2023)
5.1.3 North America Bio-based Pentylenediamine Sales in Value by Country (2018-2023)
5.2 North America Bio-based Pentylenediamine Forecasted Market Size by Country
5.2.1 North America Bio-based Pentylenediamine Sales in Volume by Country (2024-2029)
5.2.2 North America Bio-based Pentylenediamine Sales in Value by Country (2024-2029)
6 Europe Bio-based Pentylenediamine by Country
6.1 Europe Bio-based Pentylenediamine Historic Market Size by Country
6.1.1 Europe Bio-based Pentylenediamine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Bio-based Pentylenediamine Sales in Volume by Country (2018-2023)
6.1.3 Europe Bio-based Pentylenediamine Sales in Value by Country (2018-2023)
6.2 Europe Bio-based Pentylenediamine Forecasted Market Size by Country
6.2.1 Europe Bio-based Pentylenediamine Sales in Volume by Country (2024-2029)
6.2.2 Europe Bio-based Pentylenediamine Sales in Value by Country (2024-2029)
7 Asia-Pacific Bio-based Pentylenediamine by Region
7.1 Asia-Pacific Bio-based Pentylenediamine Historic Market Size by Region
7.1.1 Asia-Pacific Bio-based Pentylenediamine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Bio-based Pentylenediamine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Bio-based Pentylenediamine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Bio-based Pentylenediamine Forecasted Market Size by Region
7.2.1 Asia-Pacific Bio-based Pentylenediamine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Bio-based Pentylenediamine Sales in Value by Region (2024-2029)
8 Latin America Bio-based Pentylenediamine by Country
8.1 Latin America Bio-based Pentylenediamine Historic Market Size by Country
8.1.1 Latin America Bio-based Pentylenediamine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Bio-based Pentylenediamine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Bio-based Pentylenediamine Sales in Value by Country (2018-2023)
8.2 Latin America Bio-based Pentylenediamine Forecasted Market Size by Country
8.2.1 Latin America Bio-based Pentylenediamine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Bio-based Pentylenediamine Sales in Value by Country (2024-2029)
9 Middle East and Africa Bio-based Pentylenediamine by Country
9.1 Middle East and Africa Bio-based Pentylenediamine Historic Market Size by Country
9.1.1 Middle East and Africa Bio-based Pentylenediamine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Bio-based Pentylenediamine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Bio-based Pentylenediamine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Bio-based Pentylenediamine Forecasted Market Size by Country
9.2.1 Middle East and Africa Bio-based Pentylenediamine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Bio-based Pentylenediamine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Cathay Biotech Inc.
10.1.1 Cathay Biotech Inc. Company Information
10.1.2 Cathay Biotech Inc. Introduction and Business Overview
10.1.3 Cathay Biotech Inc. Bio-based Pentylenediamine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Cathay Biotech Inc. Bio-based Pentylenediamine Products Offered
10.1.5 Cathay Biotech Inc. Recent Development
10.2 Aphena Pharma Solutions
10.2.1 Aphena Pharma Solutions Company Information
10.2.2 Aphena Pharma Solutions Introduction and Business Overview
10.2.3 Aphena Pharma Solutions Bio-based Pentylenediamine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Aphena Pharma Solutions Bio-based Pentylenediamine Products Offered
10.2.5 Aphena Pharma Solutions Recent Development
10.3 Bio-Tech Pharmacal
10.3.1 Bio-Tech Pharmacal Company Information
10.3.2 Bio-Tech Pharmacal Introduction and Business Overview
10.3.3 Bio-Tech Pharmacal Bio-based Pentylenediamine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Bio-Tech Pharmacal Bio-based Pentylenediamine Products Offered
10.3.5 Bio-Tech Pharmacal Recent Development
10.4 Goodwin Biotechnology
10.4.1 Goodwin Biotechnology Company Information
10.4.2 Goodwin Biotechnology Introduction and Business Overview
10.4.3 Goodwin Biotechnology Bio-based Pentylenediamine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Goodwin Biotechnology Bio-based Pentylenediamine Products Offered
10.4.5 Goodwin Biotechnology Recent Development
10.5 Xenon Pharmaceuticals
10.5.1 Xenon Pharmaceuticals Company Information
10.5.2 Xenon Pharmaceuticals Introduction and Business Overview
10.5.3 Xenon Pharmaceuticals Bio-based Pentylenediamine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Xenon Pharmaceuticals Bio-based Pentylenediamine Products Offered
10.5.5 Xenon Pharmaceuticals Recent Development
10.6 Nektar Therapeutics
10.6.1 Nektar Therapeutics Company Information
10.6.2 Nektar Therapeutics Introduction and Business Overview
10.6.3 Nektar Therapeutics Bio-based Pentylenediamine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Nektar Therapeutics Bio-based Pentylenediamine Products Offered
10.6.5 Nektar Therapeutics Recent Development
10.7 Midas Pharmaceuticals
10.7.1 Midas Pharmaceuticals Company Information
10.7.2 Midas Pharmaceuticals Introduction and Business Overview
10.7.3 Midas Pharmaceuticals Bio-based Pentylenediamine Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Midas Pharmaceuticals Bio-based Pentylenediamine Products Offered
10.7.5 Midas Pharmaceuticals Recent Development
10.8 Kedrion Biopharma
10.8.1 Kedrion Biopharma Company Information
10.8.2 Kedrion Biopharma Introduction and Business Overview
10.8.3 Kedrion Biopharma Bio-based Pentylenediamine Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Kedrion Biopharma Bio-based Pentylenediamine Products Offered
10.8.5 Kedrion Biopharma Recent Development
10.9 Xcelthera
10.9.1 Xcelthera Company Information
10.9.2 Xcelthera Introduction and Business Overview
10.9.3 Xcelthera Bio-based Pentylenediamine Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Xcelthera Bio-based Pentylenediamine Products Offered
10.9.5 Xcelthera Recent Development
10.10 Anichem
10.10.1 Anichem Company Information
10.10.2 Anichem Introduction and Business Overview
10.10.3 Anichem Bio-based Pentylenediamine Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Anichem Bio-based Pentylenediamine Products Offered
10.10.5 Anichem Recent Development
10.11 ALC Bio Innovations
10.11.1 ALC Bio Innovations Company Information
10.11.2 ALC Bio Innovations Introduction and Business Overview
10.11.3 ALC Bio Innovations Bio-based Pentylenediamine Sales, Revenue and Gross Margin (2018-2023)
10.11.4 ALC Bio Innovations Bio-based Pentylenediamine Products Offered
10.11.5 ALC Bio Innovations Recent Development
10.12 ACADIA Pharmaceuticals
10.12.1 ACADIA Pharmaceuticals Company Information
10.12.2 ACADIA Pharmaceuticals Introduction and Business Overview
10.12.3 ACADIA Pharmaceuticals Bio-based Pentylenediamine Sales, Revenue and Gross Margin (2018-2023)
10.12.4 ACADIA Pharmaceuticals Bio-based Pentylenediamine Products Offered
10.12.5 ACADIA Pharmaceuticals Recent Development
10.13 AbbVie Inc.
10.13.1 AbbVie Inc. Company Information
10.13.2 AbbVie Inc. Introduction and Business Overview
10.13.3 AbbVie Inc. Bio-based Pentylenediamine Sales, Revenue and Gross Margin (2018-2023)
10.13.4 AbbVie Inc. Bio-based Pentylenediamine Products Offered
10.13.5 AbbVie Inc. Recent Development
10.14 Ology Bioservices
10.14.1 Ology Bioservices Company Information
10.14.2 Ology Bioservices Introduction and Business Overview
10.14.3 Ology Bioservices Bio-based Pentylenediamine Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Ology Bioservices Bio-based Pentylenediamine Products Offered
10.14.5 Ology Bioservices Recent Development
10.15 QMI - Quality Management
10.15.1 QMI - Quality Management Company Information
10.15.2 QMI - Quality Management Introduction and Business Overview
10.15.3 QMI - Quality Management Bio-based Pentylenediamine Sales, Revenue and Gross Margin (2018-2023)
10.15.4 QMI - Quality Management Bio-based Pentylenediamine Products Offered
10.15.5 QMI - Quality Management Recent Development
10.16 Biomiga
10.16.1 Biomiga Company Information
10.16.2 Biomiga Introduction and Business Overview
10.16.3 Biomiga Bio-based Pentylenediamine Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Biomiga Bio-based Pentylenediamine Products Offered
10.16.5 Biomiga Recent Development
10.17 Molecular Targeting Technologies
10.17.1 Molecular Targeting Technologies Company Information
10.17.2 Molecular Targeting Technologies Introduction and Business Overview
10.17.3 Molecular Targeting Technologies Bio-based Pentylenediamine Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Molecular Targeting Technologies Bio-based Pentylenediamine Products Offered
10.17.5 Molecular Targeting Technologies Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Bio-based Pentylenediamine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Bio-based Pentylenediamine Industrial Chain Analysis
11.4 Bio-based Pentylenediamine Market Dynamics
11.4.1 Bio-based Pentylenediamine Industry Trends
11.4.2 Bio-based Pentylenediamine Market Drivers
11.4.3 Bio-based Pentylenediamine Market Challenges
11.4.4 Bio-based Pentylenediamine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Bio-based Pentylenediamine Distributors
12.3 Bio-based Pentylenediamine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer